PROPOFOL Recall D-1115-2022
Description: Diprivan (Propofol) Emulsion, 100 mg/mL, 10mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-10
PROPOFOL Recall D-1115-2022 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-1115-2022 |
| Event ID | 89646 |
| Brand | DIPRIVAN |
| Generic Name | PROPOFOL |
| Manufacturer | PROPOFOL |
| Original Package? | 1 |
| Active Substance | PROPOFOL |
| Drug Route | INTRAVENOUS |
| Distribution | USA nationwide. |
| Quantity | 122 cartons |
| Recall Reason | cGMP deviations: Temperature abuse |
| Drug Classification | Class II |
| Drug Code Info | 20220615 |
| Product NDC | 63323-269 |
| Product NUI | N0000175975 N0000175681 |
| Drug UPC | 0363323269227 |
| Pharma Class (PE) | General Anesthesia [PE] |
| Pharma Class (EPC) | General Anesthetic [EPC] |
| Recall Initiation Date | 20220413 |
| Report Date | 20220615 |
| Classification Date | 20220609 |
| Address | 9954 Maryland DriveDeep Run Iii Ste. 4000 Richmond, VA 23233 United States |
| Recalling Firm | Mckesson Medical-Surgical Inc. Corporate Office |
| Initial Notification | Letter |
| Unique Ingredient Identifier | YI7VU623SF |
| Drug Application Number | NDA019627 |
| Structured Product Labeling (SPL ID) | 824826e9-2ac5-44af-a014-8e33c30d5598 |
| Structured Product Labeling (SPL Set ID) | ee0c3437-614d-4631-a061-257f5f60c70b |
| Similar To |